ALTERNATIVE FISTULA RISK SCORE AND FIRST POSTOPERATIVE DAY DRAIN FLUID AMYLASE AS PREDICTORS OF PANCREATIC FISTULA AFTER PANCREATICODUODENECTOMY.
Journal
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
ISSN: 2317-6326
Titre abrégé: Arq Bras Cir Dig
Pays: Brazil
ID NLM: 9100283
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
08
2022
accepted:
30
01
2023
medline:
25
5
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
epublish
Résumé
The high morbidity and mortality rates of pancreaticoduodenectomy are mainly associated with pancreaticojejunal anastomosis, the most fragile and susceptible to complications such as clinically relevant postoperative pancreatic fistula. The alternative fistula risk score and the first postoperative day drain fluid amylase are predictors of the occurrence of clinically relevant postoperative pancreatic fistula. No consensus has been reached on which of the scores is a better predictor; moreover, their combined predictive power remains unclear. To the best of our knowledge, this association had not yet been studied. This study assessed the predictive effect of alternative fistula risk score and/or drain fluid amylase on clinically relevant postoperative pancreatic fistula in a retrospective cohort of 58 patients following pancreaticoduodenectomy. The Shapiro-Wilk and Mann-Whitney tests were applied for assessing the distribution of the samples and for comparing the medians, respectively. The receiver operating characteristics curve and the confusion matrix were used to analyze the predictive models. The alternative fistula risk score values were not statistically different between patients in the clinically relevant postoperative pancreatic fistula and non- clinically relevant postoperative pancreatic fistula groups (Mann-Whitney U test 59.5, p=0.12). The drain fluid amylase values were statistically different between clinically relevant postoperative pancreatic fistula and non- clinically relevant postoperative pancreatic fistula groups (Mann-Whitney U test 27, p=0.004). The alternative fistula risk score and drain fluid amylase were independently less predictive for clinically relevant postoperative pancreatic fistula, compared to combined alternative fistula risk score + drain fluid amylase. The combined model involving alternative fistula risk score >20% + drain fluid amylase=5,000 U/L was the most effective predictor of clinically relevant postoperative pancreatic fistula occurrence following pancreaticoduodenectomy.
Sections du résumé
BACKGROUND
BACKGROUND
The high morbidity and mortality rates of pancreaticoduodenectomy are mainly associated with pancreaticojejunal anastomosis, the most fragile and susceptible to complications such as clinically relevant postoperative pancreatic fistula.
AIMS
OBJECTIVE
The alternative fistula risk score and the first postoperative day drain fluid amylase are predictors of the occurrence of clinically relevant postoperative pancreatic fistula. No consensus has been reached on which of the scores is a better predictor; moreover, their combined predictive power remains unclear. To the best of our knowledge, this association had not yet been studied.
METHODS
METHODS
This study assessed the predictive effect of alternative fistula risk score and/or drain fluid amylase on clinically relevant postoperative pancreatic fistula in a retrospective cohort of 58 patients following pancreaticoduodenectomy. The Shapiro-Wilk and Mann-Whitney tests were applied for assessing the distribution of the samples and for comparing the medians, respectively. The receiver operating characteristics curve and the confusion matrix were used to analyze the predictive models.
RESULTS
RESULTS
The alternative fistula risk score values were not statistically different between patients in the clinically relevant postoperative pancreatic fistula and non- clinically relevant postoperative pancreatic fistula groups (Mann-Whitney U test 59.5, p=0.12). The drain fluid amylase values were statistically different between clinically relevant postoperative pancreatic fistula and non- clinically relevant postoperative pancreatic fistula groups (Mann-Whitney U test 27, p=0.004). The alternative fistula risk score and drain fluid amylase were independently less predictive for clinically relevant postoperative pancreatic fistula, compared to combined alternative fistula risk score + drain fluid amylase.
CONCLUSION
CONCLUSIONS
The combined model involving alternative fistula risk score >20% + drain fluid amylase=5,000 U/L was the most effective predictor of clinically relevant postoperative pancreatic fistula occurrence following pancreaticoduodenectomy.
Identifiants
pubmed: 37222385
pii: S0102-67202023000100309
doi: 10.1590/0102-672020230002e1728
pmc: PMC10202466
pii:
doi:
Substances chimiques
Amylases
EC 3.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1728Références
Ann Surg. 2014 Apr;259(4):605-12
pubmed: 24374513
J Am Coll Surg. 2017 May;224(5):816-825
pubmed: 28408176
Ann Surg. 2007 Aug;246(2):281-7
pubmed: 17667507
Ann Surg. 2021 Feb 1;273(2):334-340
pubmed: 30829699
Arq Bras Cir Dig. 2021 Oct 15;34(2):e1592
pubmed: 34669882
J Hepatobiliary Pancreat Sci. 2019 Aug;26(8):354-359
pubmed: 31125494
Asian J Surg. 2021 Jan;44(1):143-146
pubmed: 32409242
Arq Bras Cir Dig. 2022 Nov 25;35:e1697
pubmed: 36449866
Medicine (Baltimore). 2018 Sep;97(38):e12487
pubmed: 30235751
Ann Surg. 2017 Jun;265(6):1209-1218
pubmed: 27280502
Ann Surg. 2019 May;269(5):937-943
pubmed: 29240007
J Gastrointest Surg. 2014 Nov;18(11):1902-10
pubmed: 25112411
Hepatogastroenterology. 2003 Jul-Aug;50(52):1155-8
pubmed: 12846003
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
Pancreas. 2018 Jan;47(1):12-17
pubmed: 29232341
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Ann Surg. 2006 Jul;244(1):1-7
pubmed: 16794381
Cochrane Database Syst Rev. 2017 Apr 07;4:CD012009
pubmed: 28386958
World J Gastroenterol. 2017 Mar 21;23(11):2044-2051
pubmed: 28373771
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
J Surg Res. 2019 Apr;236:332-339
pubmed: 30694774
Arq Bras Cir Dig. 2018 Mar 01;31(1):e1345
pubmed: 29513806
Ann Surg. 2013 Dec;258(6):1051-8
pubmed: 23360918
J Gastrointest Surg. 2015 Jan;19(1):21-30; discussion 30-1
pubmed: 25183409
Pancreatology. 2020 Jun;20(4):751-756
pubmed: 32340876
HPB (Oxford). 2020 Jan;22(1):58-66
pubmed: 31272847
Surgery. 2020 Feb;167(2):442-447
pubmed: 31727324
Ann Surg. 2019 Jun;269(6):1146-1153
pubmed: 31082914
Br J Surg. 2016 Mar;103(4):328-36
pubmed: 26791838
Ann Surg. 2019 Feb;269(2):337-343
pubmed: 28938266
Medicine (Baltimore). 2016 Feb;95(5):e2569
pubmed: 26844462
J Am Coll Surg. 2015 Oct;221(4):798-809
pubmed: 26278037